Skip to content

13F-HR filed by LINCOLN CAPITAL CORP

LINCOLN CAPITAL CORP filed this 13F-HR for the quarter ended 2017-09-30, filed 2017-10-18, with 45 holding rows worth $111,891,000.

Accession
0001085146-17-002082
Filed
2017-10-18
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2017

A holdings report, 45 entries on the cover page, a total value of $111,891,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $111,891,000 with VALUE read as thousands by filing date, 13F file number 028-17993. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Schwab US TIPS ETF808524870SHS173,555$9,591,000thousands by filing date
Microsoft Corp594918104COM92,518$6,892,000thousands by filing date
TEXTRON INC COM883203101Stock121,705$6,557,000thousands by filing date
Schwab U.S. Broad Market ETF808524102SHS82,500$5,025,000thousands by filing date
NXP SEMICONDUCTORS N V COMN6596X109Stock41,723$4,718,000thousands by filing date
CELGENE CORP151020104COM31,876$4,648,000thousands by filing date
GENERAL ELEC CO369604103COM190,001$4,594,000thousands by filing date
Johnson & Johnson478160104COM33,794$4,394,000thousands by filing date
AbbVie,Inc.00287Y109COM49,361$4,386,000thousands by filing date
Oracle Corporation68389X105COM88,548$4,281,000thousands by filing date
Abbott Laboratories002824100COM80,148$4,277,000thousands by filing date
BANK OF NY MELLON CORP COM064058100Stock79,203$4,199,000thousands by filing date
Merck & Co.,Inc.58933Y105COM64,840$4,152,000thousands by filing date
METLIFE INC COM59156R108Stock75,946$3,945,000thousands by filing date
CVS Health Corporation126650100COM45,209$3,676,000thousands by filing date
JPMorgan Chase & Co46625H100COM36,093$3,447,000thousands by filing date
Amgen Inc.031162100COM18,480$3,446,000thousands by filing date
ConocoPhillips20825C104COM57,186$2,862,000thousands by filing date
KANSAS CITY SOUTHERN485170302COM NEW25,002$2,717,000thousands by filing date
PROSHARES TR74348A467S&P 500 DV ARIST42,617$2,534,000thousands by filing date
APACHE CORP037411105COM48,103$2,203,000thousands by filing date
WYNDHAM DESTINATIONS INC98310W108COM17,752$1,871,000thousands by filing date
Schlumberger Limited806857108COM26,558$1,853,000thousands by filing date
KROGER CO COM501044101Stock76,085$1,526,000thousands by filing date
Schwab US Mid-Cap ETF808524508SHS30,311$1,519,000thousands by filing date
Schwab U.S. Large-Cap ETF808524201SHS23,581$1,416,000thousands by filing date
PNC FINL SVCS GROUP INC COM693475105Stock10,303$1,389,000thousands by filing date
SMUCKER J M CO832696405COM NEW12,757$1,389,000thousands by filing date
Apple Inc037833100COM8,652$1,333,000thousands by filing date
CORNING INC219350105COM25,262$756,000thousands by filing date
UnitedHealth Group Inc91324P102COM3,600$705,000thousands by filing date
Schwab U.S. Small-Cap ETF808524607SHS9,932$669,000thousands by filing date
SPDR Bloomberg Investment Grade Floating Rate ETF78468R200SHS209,177$643,000thousands by filing date
ADVISORY BOARD CO/THE00762W107Domestic Common10,153$544,000thousands by filing date
Eaton Corp. PlcG29183103COM6,890$529,000thousands by filing date
Vanguard Dividend Appreciation ETF921908844SHS5,491$520,000thousands by filing date
iShares Core S&P Small-Cap ETF464287804SHS6,800$505,000thousands by filing date
Cisco Systems,Inc.17275R102COM12,822$431,000thousands by filing date
BRIGHTHOUSE FINL INC10922N103COM6,245$380,000thousands by filing date
Netflix, Inc64110L106COM2,020$366,000thousands by filing date
META PLATFORMS INC CL A30303M102COM2,000$342,000thousands by filing date
KERYX BIOPHARMACEUTICALS492515101COMMON STOCK36,500$259,000thousands by filing date
EXXON MOBIL CORP30231G102COM2,643$217,000thousands by filing date
ICAD INC44934S206COM NEW21,000$93,000thousands by filing date
ACELRX PHARMACEUTICALS INC00444T100COM20,000$92,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001085146-17-002082this filing2017-10-18acceptance time not in the bulk data set